Understanding the law and practice requirements for patents is important for originator and generic pharmaceutical products, such as when protecting a new pharmaceutical development or testing the validity of a patent. Changes in the patent laws in Australia and New Zealand in 2011 and 2013, respectively, implemented higher thresholds for a range of patentability requirements including: inventive step, support and enablement. Various decisions have issued clarifying these higher patentability requirements. This talk will focus on different aspects of pharmaceutical patent practice in the region, ranging from considerations relating to the inventive step, clarity and support criterion for claims encompassing Markush structures or polymorphs, through to practice tips for obtaining a patent term extension in Australia.

Best practice strategies for prosecuting pharmaceutical patents in Australia, New Zealand and South East Asia

Fall 2022 abstracts, posters, and presentations will launch in mid-September.

ACS Fall 2022

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.